413 related articles for article (PubMed ID: 27618752)
1. Precision Medicine in Myelodysplastic Syndromes and Leukemias: Lessons from Sequential Mutations.
Nazha A; Sekeres MA
Annu Rev Med; 2017 Jan; 68():127-137. PubMed ID: 27618752
[TBL] [Abstract][Full Text] [Related]
2. Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?
Nazha A; Sekeres MA; Gore SD; Zeidan AM
Oncologist; 2015 Sep; 20(9):1069-76. PubMed ID: 26194858
[TBL] [Abstract][Full Text] [Related]
3. Does mutational burden add to other prognostic factors in MDS?
Nazha A
Best Pract Res Clin Haematol; 2019 Dec; 32(4):101098. PubMed ID: 31779975
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between clinical features and somatic gene mutations in myelodysplastic syndrome].
Hirasawa N; Sakata-Yanagimoto M; Nannya Y; Hattori K; Suehara Y; Kato T; Yokoyama Y; Kurita N; Obara N; Ogawa S; Hasegawa Y; Chiba S
Rinsho Ketsueki; 2018; 59(1):80-83. PubMed ID: 29415943
[TBL] [Abstract][Full Text] [Related]
5. Novel therapeutic strategies in myelodysplastic syndromes: do molecular genetics help?
Chung SS
Curr Opin Hematol; 2016 Mar; 23(2):79-87. PubMed ID: 26825694
[TBL] [Abstract][Full Text] [Related]
6. Advances in Personalized Therapeutic Approaches in Myelodysplastic Syndromes.
Bejar R
J Natl Compr Canc Netw; 2019 Nov; 17(11.5):1444-1447. PubMed ID: 31766023
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implications of Genetic Mutations in Myelodysplastic Syndrome.
Kennedy JA; Ebert BL
J Clin Oncol; 2017 Mar; 35(9):968-974. PubMed ID: 28297619
[TBL] [Abstract][Full Text] [Related]
8. How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes.
Steensma DP
Blood; 2018 Oct; 132(16):1657-1663. PubMed ID: 30185432
[TBL] [Abstract][Full Text] [Related]
9. [Research Advances of Molecular Genetic Abnormality in Myelodysplastic Syndrome--Review].
Pang YB; Wu P; Hua LM; DU X; Wang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1248-1252. PubMed ID: 30111440
[TBL] [Abstract][Full Text] [Related]
10. Mutation-Driven Therapy in MDS.
Swoboda DM; Sallman DA
Curr Hematol Malig Rep; 2019 Dec; 14(6):550-560. PubMed ID: 31760573
[TBL] [Abstract][Full Text] [Related]
11. Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges.
Caponetti GC; Bagg A
Int J Lab Hematol; 2020 Dec; 42(6):671-684. PubMed ID: 32757473
[TBL] [Abstract][Full Text] [Related]
12. Surveying the landscape of MDS/MPN research: overlap among the overlap syndromes?
Padron E
Hematology Am Soc Hematol Educ Program; 2015; 2015():349-54. PubMed ID: 26637742
[TBL] [Abstract][Full Text] [Related]
13. The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes.
Zhang L; Padron E; Lancet J
Leuk Res; 2015 Jan; 39(1):6-17. PubMed ID: 25465125
[TBL] [Abstract][Full Text] [Related]
14. Trends in Clinical Investigation for Myelodysplastic Syndromes.
Prebet T; Zeidan A
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S57-63. PubMed ID: 27521326
[TBL] [Abstract][Full Text] [Related]
15. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
Chung C; Ma H
Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205
[TBL] [Abstract][Full Text] [Related]
16. Correlation of somatic mutations with outcome after FLAMSA-busulfan sequential conditioning and allogeneic stem cell transplantation in patients with myelodysplastic syndromes.
Christopeit M; Badbaran A; Alawi M; Zabelina T; Zeck G; Wolschke C; Ayuk F; Kröger N
Eur J Haematol; 2016 Sep; 97(3):288-96. PubMed ID: 26680262
[TBL] [Abstract][Full Text] [Related]
17. [Sequential acquisition of mutations in myelodysplastic syndromes].
Makishima H
Rinsho Ketsueki; 2017; 58(10):1828-1837. PubMed ID: 28978821
[TBL] [Abstract][Full Text] [Related]
18. Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?
Thol F; Platzbecker U
Blood Adv; 2019 Nov; 3(21):3449-3453. PubMed ID: 31714960
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic syndromes.
Cilloni D; Messa F; Carturan S; Arruga F; Defilippi I; Messa E; Gottardi E; Saglio G
Ann N Y Acad Sci; 2004 Dec; 1028():400-8. PubMed ID: 15650265
[TBL] [Abstract][Full Text] [Related]
20. [Treatment for myelodysplastic syndromes and future perspectives in the genomic era].
Maeda T
Rinsho Ketsueki; 2021; 62(8):1038-1049. PubMed ID: 34497190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
